Prediction models in cancer care
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Prediction is ubiquitous across the spectrum of cancer care from screening to hospice. Indeed, oncology is often primarily a prediction problem; many of the early stage cancers cause no symptoms, and treatment is recommended because of a prediction that tumor progression would ultimately threaten a patient's quality of life or survival. Recent years have seen attempts to formalize risk prediction in cancer care. In place of qualitative and implicit prediction algorithms, such as cancer stage, researchers have developed statistical prediction tools that provide a quantitative estimate of the probability of a specific event for an individual patient. Prediction models generally have greater accuracy than reliance on stage or risk groupings, can incorporate novel predictors such as genomic data, and can be used more rationally to make treatment decisions. Several prediction models are now widely used in clinical practice, including the Gail model for breast cancer incidence or the Adjuvant! Online prediction model for breast cancer recurrence. Given the burgeoning complexity of diagnostic and prognostic information, there is simply no realistic alternative to incorporating multiple variables into a single prediction model. As such, the question should not be whether but how prediction models should be used to aid decision‐making. Key issues will be integration of models into the electronic health record and more careful evaluation of models, particularly with respect to their effects on clinical outcomes. CA Cancer J Clin 2011. © 2011 American Cancer Society, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 1×
“70, is that good or bad? Or take the common question of whether a novel molecular marker is of value.(24) If use of a marker increases the concordance index of a model from 0.”
BackgroundDecision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341 · cited 1×
“A simple decision analytic solution has recently been proposed.(14)”
MethodSelf-citationAssessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Self-citationGail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334 · cited 1×
“The Gail model predicts a woman’s risk of invasive breast cancer within 5 years on the basis of age, race, family history, age at first menses, age of first live birth, and relevant medical history (eg, prior negative breast biopsy).(32) An online version of the prediction model is available at http://www.”
Prognosis and prognostic research: application and impact of prognostic models in clinical practice
Moons, K. G. M., Altman, D. G., Vergouwe, Y., & Royston, P. (2009) · BMJ · doi:10.1136/bmj.b606 · Cited by 934
Reilly, B. M., & Evans, A. T. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00009 · Cited by 794
Everything you always wanted to know about evaluating prediction models (but were too afraid to ask)
Vickers, A. J., & Cronin, A. M. (2010) · Urology · doi:10.1016/j.urology.2010.06.019 · Cited by 112
Self-citation
Cited by
Prediction of acute myeloid leukaemia risk in healthy individuals
Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., et al. (2018) · Nature · doi:10.1038/s41586-018-0317-6 · Cited by 850
Collins, G. S., de Groot, J. A., Dutton, S., Omar, O., Shanyinde, M., Tajar, A., Voysey, M., Wharton, R., Yu, L.-M., Moons, K. G., et al. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-40 · Cited by 729
“Key characteristics, such as calibration and discrimination, are widely recommended aspects to evaluate [9,12-15,26,45,46].”
BackgroundElectronic patient‐reported outcome systems in oncology clinical practice
Bennett, A. V., Jensen, R. E., & Basch, E. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21150 · Cited by 353
Maguire, R., Fox, P. A., McCann, L., Miaskowski, C., Kotronoulas, G., Miller, M., Furlong, E., Ream, E., Armes, J., Patiraki, E., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015016 · Cited by 172
“Complementary to such technological innovations is the advent of predictive risk models (PRMs) which enable care to be effectively triaged and clinicians to employ a preventative and anticipatory model of care through identification of patients at greatest risk for CTX-related symptoms.(40) Collectively, the use of te…”
BackgroundMoradian, S., Krzyzanowska, M. K., Maguire, R., Morita, P. P., Kukreti, V., Avery, J., Liu, G., Cafazzo, J., & Howell, D. (2018) · JMIR Cancer · doi:10.2196/10932 · Cited by 56
“The ASyMs uses innovative risk prediction modeling and decision-support tools that allow for timely, high-quality, person-centered supportive care for better treatment toxicity management [10,16].”
BackgroundMethod
Metadata
- Authors
- Vickers, A. J.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2011-06-23
- Volume
- 61
- Issue
- 5
- Pages
- 315-326
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W1970705355
- Cited by
- 111
- References
- 7
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.